Search Press releases Keywords From To 10 Nov 2009 Ismail Kola joins UCB as Executive Vice President, UCB & President of UCB New Medicines(TM) Read More 6 Nov 2009 UCB Extraordinary General Meeting Read More 27 Oct 2009 UCB successfully completes its fixed rate bonds - Early termination of the offer period - Total amount is set at EUR 750 million Read More 23 Oct 2009 UCB to offer a minimum of EUR 150 million[1] in 5-year fixed rate bonds Read More 22 Oct 2009 Interim Report - Promising early results for UCB's new products Read More 5 Oct 2009 Cimzia®, the only PEGylated anti-TNF, approved in Europe and available in a syringe designed in partnership with OXO Good Grips® Read More Pagination First page Previous page Previous … Page 162 Page 163 Page 164 Page 165 Current page 166 Page 167 Page 168 Page 169 Page 170 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
